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Abstract 
Several case-control studies have reported that patients with diabetes mellitus (DM) had a higher prevalence of 
Helicobacter pylori infection than those without DM, but these findings remain equivocal. Additionally, there are few 
studies examining associations between East Asian CagA-positive H. pylori and DM. This cross-sectional study aimed 
to investigate whether H. pylori infection was a possible risk factor for DM in a general Japanese population. The study 
included 5165 subjects (1467 men, 3698 women) aged 35–69 years from the Daiko Study, part of the Japan Multi-
Institutional Collaborative Cohort Study. A urinary anti-H. pylori antibody was used to detect H. pylori infection. The 
medical history of physician-diagnosed DM was confirmed by self-administered questionnaire. The odds ratios (ORs) 
and their 95 % confidence intervals (CIs) for DM (current and former) were calculated using unconditional logistic 
regression analysis, adjusting for age, sex, educational status, alcohol use, smoking status, body mass index, energy 
intake, and physical activity. The prevalence of DM was 4.6 % (95 % CI 3.7–5.6 %) among 1878 participants with H. 
pylori infection and 3.2 % (2.6–3.8 %) among 3287 without the infection (p = 0.009). The crude, age-adjusted, and 
multivariate-adjusted ORs for DM in those with the infection relative to those without were 1.47 (95 % CI 1.10–1.97), 
1.02 (0.76–1.38), and 0.97 (0.71–1.32), respectively. We found a significantly higher DM prevalence among those with 
H. pylori infection than among those without. However, almost all the difference in prevalence could be explained by 
the older age of those infected. Our findings did not support an association between H. pylori infection and DM.
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Background
Helicobacter pylori infection is a major risk factor for gas-
tric cancer (Montecucco and Rappuoli 2001) and is also 
well known as a causative factor for ulcers, atrophic gas-
tritis, mucosa-associated lymphoid tissue lymphoma, and 
intestinal metaplasia (Labenz and Borsch 1994; Asaka 
et  al. 2001; Wundisch et  al. 2005). Helicobacter pylori 
infection has been estimated to be present in half of the 
world’s population, and it has been reported to be higher 
in developing countries than in industrialized countries 
(Suerbaum and Michetti 2002; Correa and Piazuelo 
2008).
Some studies reported that H. pylori is a possible risk 
factor for cardiovascular disease and metabolic syndrome, 
potentially mediated by elevations in inflammatory mol-
ecules, such as C-reactive protein and interleukin-6 
(Georges et  al. 2003; Nabipour et  al. 2006). Helicobacter 
pylori infection has been linked with the activation of 
toll-like receptors, resulting in energy harvesting and fat 
accumulation, which lead to insulin resistance (Manco 
et  al. 2010). Several cross-sectional studies showed that 
H. pylori infection was associated with diabetes mellitus 
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(DM) (Chen and Blaser 2012; Hsieh et al. 2013; Han et al. 
2015). A recent prospective cohort study also reported 
that H. pylori infection was correlated with a significantly 
high hazard ratio for DM (Jeon et  al. 2012). However, 
the association between H. pylori infection and the risk 
of DM remains controversial, because several cross-sec-
tional studies reported that H. pylori was not associated 
with insulin resistance or the prevalence of DM (Ko et al. 
2001; Anastasios et  al. 2002; Howard et  al. 2008; Lutsey 
et al. 2009), and there are few studies reporting such asso-
ciations among large populations in East Asia, where the 
more pathogenic East Asian CagA-positive strain of H. 
pylori is dominant (Fock and Ang 2010).
We previously reported the prevalence of H. pylori 
infection in 2008–2010 among a large general Japanese 
population (Tamura et al. 2012). In the present study, we 
aimed to investigate whether or not H. pylori infection 
was associated with DM in a cross-sectional study in the 
same population.
Methods
Subjects, lifestyle, and medical history of diabetes mellitus
The study included 5165 participants (1467 men, 3698 
women) aged 35–69 years in the Daiko Study, part of the 
Japan Multi-Institutional Collaborative Cohort Study 
(J-MICC Study) (The J-MICC Study Groups 2007; Morita 
et al. 2011). The participants were enrolled at the Daiko 
Medical Center from June 2008 to May 2010.
All participants provided written informed consent and 
completed a questionnaire on their lifestyle, including 
education, alcohol use, smoking status, exercise, dietary 
habits, history of H. pylori eradication treatment, and 
medical history of physician-diagnosed DM (current, for-
mer, or never). Of 5172 initial participants, we excluded 
four who withdrew from the study, two with no answer 
about their DM medical history, and one without a urine 
sample for the detection of anti-H. pylori antibody. The 
J-MICC Study and the Daiko Study were both approved 
by the Ethics Review Committee of Nagoya University 
School of Medicine (approved numbers were 253 and 
618, respectively).
Detection of H. pylori infection
An antibody kit for urine, Rapiran (Otsuka Pharmaceuti-
cal Co., Ltd., Tokyo, Japan) was used to detect H. pylori 
infection. The sensitivity and specificity of the assay were 
89.6 and 93.8 %, respectively, based on biopsies of gastric 
mucosa as a gold standard (Yamamoto et al. 2000; Gra-
ham and Reddy 2001; Fujisawa et al. 2001).
Estimation of physical activity levels
The daily metabolic equivalent (MET)-hours/day 
(MET levels × hours/day) were estimated based on our 
questionnaire. Subjects were asked about the average 
hours per day (none, <1, 1 to <3, 3 to <5, 5 to <7, 7 to 
<9, 9 to <11, and ≥11 h) of four types of physical activ-
ity: heavy physical work, walking, standing, and sitting. 
The following time scores were assigned: 0 for none, 0.5 
for <1, 2 for 1 to <3, 4 for 3 to <5, 6 for 5 to <7, 8 for 7 
to <9, 10 for 9 to <11, and 11 for ≥11  h. On the basis 
of previous studies (Inoue et al. 2008a, b), the following 
MET scores were assigned: 4.5 for heavy physical work, 
3.0 for walking, 2.0 for standing, and 1.5 for sitting. We 
defined and included only ≥3.0 METs activity as physi-
cal activity, and each MET-hours/day (i.e., heavy physi-
cal work and walking) was calculated by multiplying the 
MET intensity for each activity by the daily time score 
for each activity.
Leisure-time physical activity was calculated using the 
international physical activity questionnaire (IPAQ) as 
in a previous study (Higashibata et  al. 2012). IPAQ was 
developed and validated as an instrument for cross-
national monitoring of physical activity and inactivity 
(Craig et  al. 2003). Total MET-hours/day (total physical 
activity) were then estimated by adding the sum of daily 
physical activity to that of leisure time for those who 
responded to all the questions (n = 5101).
Estimation of total energy intake
Energy intake (kcal/day) was estimated using a short 
food frequency questionnaire for each subject. The ques-
tionnaire has been validated for estimation of energy 
and nutrient intakes in Japanese subjects by referring to 
dietary records (Tokudome et al. 2004, 2005; Goto et al. 
2006; Imaeda et al. 2007).
Statistical analysis
Differences in mean values between those with and with-
out H. pylori infection were examined by the Student t 
test, and the differences in proportions were tested using 
the Chi square test. Confidence intervals (CIs) of H. 
pylori infection or DM prevalence were estimated based 
on a binominal distribution.
We calculated a prevalence rate ratio of DM for the 
infection. Additionally, the following odds ratios (ORs) of 
DM (current or former) for H. pylori infection (positive) 
with their 95 % CIs were estimated using unconditional 
logistic regression models: crude OR, age-adjusted OR, 
age- and sex-adjusted OR, and multivariate-adjusted OR, 
adjusted for age (as a continuous variable), sex, education 
(≤12, 13–15, or ≥16 years), alcohol use (current, former, 
or never), smoking status (current, former, or never), 
body mass index (BMI, as a continuous variable), energy 
intake (as a continuous variable), and total physical activ-
ity (as a continuous variable) as confounders. Those who 
drank at least once a month were defined as current 
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drinkers. Those with any covariate missing were excluded 
from the multivariate analysis (n = 85).
The statistical power to detect given ORs for DM with 
an α error of 0.05 was calculated based on the sample 
size, the infection rate of H. pylori, and the DM preva-
lence after study completion. A p-value of <0.05 was con-
sidered statistically significant. All the statistical analyses 
were performed using STATA/IC 12.1 (STATA Corp., 
College Station, TX, USA).
Results
Table  1 compares the characteristics of 5165 study 
subjects between those with H. pylori infection and 
those without. In total, 28.4  % were men and 71.6  % 
were women. Mean age  ±  standard deviation was 
53.6 ± 10.3 years in men and 52.2 ± 10.3 years in women, 
with 58.5 % of participants aged ≥50 years. A total of 190 
participants reported a history of DM (current or for-
mer) in the questionnaire. Participants without H. pylori 
infection tended to have a higher education. The pro-
portions of current drinkers were 55.0 % for those with-
out infection and 52.6 % for those with infection, while 
respective proportions of current smokers were 11.3 and 
12.7 %; these differences were not statistically significant. 
Means of age and BMI were significantly higher in those 
with H. pylori infection than those without (p  <  0.001 
and p = 0.002, respectively). Mean total physical activity 
was marginally higher in those with the infection than in 
those without (p = 0.09). Average energy intake was not 
significantly different between those with and without 
infection.
Figure 1 shows the DM prevalence according to infec-
tion status and age. The prevalence was 4.6  % (95  % CI 
3.7–5.6  %) among those with H. pylori infection and 
3.2 % (95 % CI 2.6–3.8 %) among those without, result-
ing in a significant difference (p = 0.009). The difference 
within each age group, however, did not reach statistical 
significance.
Table  2 summarizes the ORs for DM in relation to 
H. pylori infection. The prevalence rate ratio and the 
crude OR of DM for those with the infection relative 
to those without were greater than unity: 1.45 (95 % CI 
1.09–1.91) and 1.47 (95  % CI 1.10–1.97), respectively. 
The age-adjusted OR, however, showed no association: 
1.02 (95 % CI 0.76–1.38). The age- and sex-adjusted and 
the multivariate-adjusted ORs also indicated no associ-
ation: 0.98 (95 % CI 0.72–1.32) and 0.97 (95 % CI 0.71–
1.32), respectively. Including 167 H. pylori-negative 
subjects who had a history of eradication treatment as 
positive subjects had little effect on the ORs (date not 
shown).
Discussion
In this study, we examined the association of H. pylori 
infection with medical history of DM. Overall, DM prev-
alence was significantly higher in those with H. pylori 
infection than those without infection. However, after 
adjusting for age as a confounder, H. pylori infection was 
not associated with DM in a general Japanese population.
Helicobacter pylori is transmitted from person to per-
son through oral-oral or fecal-oral routes during early 
childhood (from 1 to 3 years old), and the infection usu-
ally persists unless eradication therapy has been suc-
cessful (Goodman and Correa 1995). Infection among 
adults is possible, but highly limited (Brown 2000). Thus, 
H. pylori-positive subjects in this study would have 
been infected for decades (Tamura et  al. 2012). Several 
case-control studies have reported that H. pylori infec-
tion was significantly associated with DM (Bener et  al. 
2007; Devrajani et  al. 2010). Additionally, a prospective 
cohort study and a meta-analysis of observational stud-
ies also showed that H. pylori infection is a risk factor for 
DM (Jeon et al. 2012; Zhou et al. 2013). Some biological 
mechanisms may explain the association. First, altered 
glucose metabolism may produce chemical changes in 
the gastric mucosa that help to detect H. pylori infec-
tion (de Luis et al. 1998). Second, H. pylori gastric infec-
tion increases secretion of proinflammatory cytokines, 
resulting in changes in the structure of insulin recep-
tor interfering with the interaction between its receptor 
and insulin (Bener et  al. 2007). Our study also found a 
significantly higher prevalence rate ratio and crude OR 
of DM in relation to H. pylori infection. However, the 
age-adjusted OR was almost unity, which means that 
the significant difference in prevalence of DM between 
those with and without the infection could be explained 
by the older age of those infected and the higher preva-
lence of DM in the elderly. This explanation was further 
supported by the fact that DM prevalence was not sig-
nificantly different between infection statuses in each 
age stratum (Fig. 1). Since the risk of DM is influenced by 
lifestyle factors such as alcohol use, smoking status, die-
tary habits, and exercise, we estimated the multivariate-
adjusted ORs of DM according to infection status, and 
again found no association. Our results indicate that H. 
pylori infection may not be a risk factor for DM in Jap-
anese subjects. This is in accordance with other studies 
that found negative or neutral results for such an associa-
tion (Demir et al. 2008; Ciortescu et al. 2009).
A previous meta-analysis for the association between H. 
pylori infection and DM reported a significantly high OR 
(1.33, 95 % CI 1.08–1.64) (Zhou et al. 2013), although the 
analysis mainly included case-control studies and only 
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a few studies in East Asian populations. Our findings in 
a large Japanese population should contribute to under-
standing the association in East Asian individuals. The East 
Asian CagA-positive strain of H. pylori is a well-known risk 
factor for gastric cancer (Azuma et al. 2004). Interestingly, 
there are two major subtypes of CagA, the East Asian and 
the Western types, and the former subtype is dominant 
in Japan except for Okinawa Prefecture (Azuma 2004) on 
the southernmost islands of the country. Only one-half 
to two-thirds of Western infections carry Western CagA, 
while nearly all East Asian strains have East Asian CagA 
(Van Doorn et al. 1999). Some previous studies reporting 
the association between H. pylori and DM suggested that 
Western CagA increased the risk of DM (Jeon et al. 2012; 
Zhou et al. 2013). In contrast, our study may indicate that 
the East Asian CagA strain is not associated with DM. 
Infection with the East Asian CagA-positive strain is 
clearly involved in the pathogenesis of gastric cancer, with 
persistent inflammation induced by CagA. However, the 
increased inflammation may not necessarily enhance insu-
lin resistance and fat accumulation as has been suggested in 
previous studies in Asian populations (Howard et al. 2008; 
Lutsey et al. 2009). The mechanism by which only Western 
strains induced DM remains to be elucidated.
Table 1 Background characteristics of the study subjects according to H. pylori infection
BMI body mass index, SD standard deviation, MET metabolic equivalent
a Data were missing for one subject with no information on body weight
Characteristic Total (n = 5165) H. pylori
Uninfected (n = 3287) Infected (n = 1878) p
Age (years)
 Mean ± SD 52.5 ± 10.3 50.7 ± 10.3 55.8 ± 9.6 <0.001
 Range 35–69 35–69 35–69
Sex, n (%)
 Men 1467 (28.4) 891 (27.1) 576 (30.7) 0.006
 Women 3698 (71.6) 2396 (72.9) 1302 (69.3)
Diabetes mellitus, n (%)
 Current 156 (3.0) 84 (2.6) 72 (3.8) 0.07
 Former 34 (0.7) 20 (0.6) 14 (0.8)
 None 4975 (96.3) 3183 (96.8) 1792 (95.4)
Education, n (%)
 ≤12 years 2088 (40.4) 1213 (36.9) 875 (46.6) <0.001
 ≥13–15 years 1535 (29.7) 1025 (31.2) 510 (27.2)
 ≥16 years 1524 (29.5) 1037 (31.5) 487 (25.9)
 Unknown 18 (0.4) 12 (0.4) 6 (0.3)
Alcohol use, n (%)
 Current 2798 (54.2) 1809 (55.0) 989 (52.6) 0.24
 Former 105 (2.0) 61 (1.9) 44 (2.4)
 Never 2261 (43.8) 1416 (43.1) 845 (45.0)
 Unknown 1 (0.02) 1 (0.03) 0 (0.0)
Smoking status, n (%)
 Current 609 (11.8) 371 (11.3) 238 (12.7) 0.10
 Former 1025 (19.8) 636 (19.3) 389 (20.7)
 Never 3530 (68.3) 2280 (69.4) 1250 (66.6)
 Unknown 1 (0.02) 0 (0.0) 1 (0.05)
BMI (kg/m2)a
 Mean ± SD 21.7 ± 3.2 21.6 ± 3.2 21.9 ± 3.2 0.002
 Range 11.5–52.8 13.6–42.4 11.5–52.8
Energy intake (kcal/day)
 Mean ± SD 1612 ± 326 1611 ± 324 1614 ± 329 0.35
Physical activity (MET-hours/day)
 Mean ± SD 14.5 ± 9.0 14.3 ± 8.9 14.8 ± 9.1 0.09
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Our study involved a large population that lends sup-
port to our conclusion. There are limitations in this study. 
First, fasting blood glucose level and glycosylated hemo-
globin (HbA1c) values were not directly measured. How-
ever, the sensitivity and specificity of our questionnaire 
for DM were 74.4 and 98.1  %, respectively, when based 
on a HbA1c (National Glycohemoglobin Standardization 
Program) value ≥6.5  %, which was the gold standard 
for diagnosis of DM among 5009 subjects in the Shi-
zuoka area, in another part of the J-MICC study (Asai 
et  al. 2009). Therefore, we believe that case ascertain-
ment using self-report was reasonably valid for the pre-
sent study. Second, we could not differentiate the type of 
DM (type 1 or 2) due to the limitation of data, but the 
prevalence of type 1 DM in Japan is much lower than that 
of type 2 DM (International Diabetes Federation 2013). 
Third, we did not use the well-validated serological tests 
for Helicobacter pylori infection. However, according to 
previous studies, the sensitivity and specificity of urinary 
test used in our study are similar to those of the validated 
serological tests (Yamamoto et  al. 2000; Burucoa et  al. 
2013). We employed the urinary test because it could 
be superior to serum tests in terms of the convenience 
and non-invasiveness to participants. Finally, this study 
had statistical power of 69.2, 74.6, and 83.6  % to detect 
ORs of 1.45, 1.50, and 1.55, respectively, for the infected 
versus uninfected. The power was 43.7 %, if the true OR 
was 1.33 based on a previous meta-analysis (Zhou et al. 
2013). This study had a relatively high β error possibil-
ity (i.e., 56.3  %) to overlook such an association, which 
means that a slight increase in the risk for DM in relation 
to H. pylori cannot be ruled out.
Conclusion
Our findings suggest that infection of East Asia CagA-
positive H. pylori is not a risk factor for DM. Further 
prospective cohort studies of non-DM subjects with or 
without H. pylori infection are warranted.
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Fig. 1 Prevalence of diabetes mellitus among those with H. pylori 
infection and those without. DM diabetes mellitus. Numbers at tops of 
bars show n of DM (+)/n. Error bars indicate 95 % confidence intervals
Table 2 Prevalence rate ratio and  odds ratios and  95  % 
confidence intervals for diabetes mellitus in relation to H. 
pylori infection
OR odds ratio
a Adjusted for age, sex, education, alcohol use, smoking status, BMI, energy 
intake, and total physical activity
H. pylori
Uninfected (n = 3287) Infected (n = 1878)
Diabetes mellitus
 Never, n (%) 3183 (96.8) 1792 (95.4)
 Current or former, n (%) 104 (3.2) 86 (4.6)
 Prevalence rate ratio 1 1.45 (1.09–1.91)
 Crude OR 1 1.47 (1.10–1.97)
 Age-adjusted OR 1 1.02 (0.76–1.38)
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